Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy.

MLA

El-Shamy, Ahmed, et al. “Polymorphisms of Hepatitis C Virus Non-Structural Protein 5A and Core Protein and Clinical Outcome of Pegylated-Interferon/Ribavirin Combination Therapy.” Intervirology, vol. 55, no. 1, 2012, pp. 1–11. EBSCOhost, https://doi.org/10.1159/000322219.

APA

El-Shamy, A., Kim, S.-R., Ide, Y.-H., Sasase, N., Imoto, S., Deng, L., Shoji, I., & Hotta, H. (2012). Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy. Intervirology, 55(1), 1–11. https://doi.org/10.1159/000322219

Chicago

El-Shamy, Ahmed, Soo-Ryang Kim, Yoshi-Hiro Ide, Noriko Sasase, Susumu Imoto, Lin Deng, Ikuo Shoji, and Hak Hotta. 2012. “Polymorphisms of Hepatitis C Virus Non-Structural Protein 5A and Core Protein and Clinical Outcome of Pegylated-Interferon/Ribavirin Combination Therapy.” Intervirology 55 (1): 1–11. doi:10.1159/000322219.